Skip to main content

Table 2 Selection criteria for studies to be included in systematic review of therapeutic outcomes of multi-drug-resistant tuberculosis and their predictors in adults receiving integrated treatment of tuberculosis and human immuno-deficiency virus in low- and middle-income countries

From: Systematic review of therapeutic outcomes of multidrug resistant tuberculosis and their predictors in adults receiving integrated treatment of tuberculosis and human immuno-deficiency virus in low- and middle-income countries: a study protocol

Item Inclusion criteria Exclusion criteria
Population Studies involving adults who are co-infected with MDR-TB and HIV in LMICs Studies involving
-Pregnant women
-Patients with multi-morbidities
Intervention Studies reporting on the delivery of integrated treatment of TB and HIV in LMICs -Studies describing treatment of only MDR-TB
-Studies describing integrated treatment of drug-sensitive TB and HIV
-Studies describing integrated treatment of more than 2 diseases (TB/HIV)
Comparison
Outcome(s) Studies reporting on MDR-TB outcomes and/or their predictors in the setting of integrated therapy for TB/HIV. Studies describing outcomes that are unrelated to treatment of MDR-TB in the context of integrated TB/HIV therapy
Study design Observational studies specifically, cohort studies that use quantitative research methods 1) Interventional studies
2) Observational studies other than cohort, e.g. cross-sectional studies
3) Mini-reviews, conference abstracts, letters to editors, editorials, commentaries.
4) Studies whose full data will not be available even upon requesting from the author
5) Duplicates studies: for studies published with the same or different titles or in more than one journal, the most updated version shall be considered.